Conference abstract · 2018
Conference abstractPublished 2019
Nuclear protein profile changes in response to infections of human metapneumovirus vaccine candidates
University of Texas Medical Branch, Texas Huazhong University of Science and Technology, China Baylor University, Texas
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Human metapneumovirus (hMPV) is a leading cause of lower respiratory infection in pediatric populations globally. This study examined the proteomic profile changes of A549 cells by hMPV and its two attenuated mutants with deleted PDZ domain binding motif(s) of M2-2 protein. These motifs are involved in the interruption of antiviral signaling, namely the interaction between the TRAFMAVS. The aim of this study is to provide insight on the overall and novel impact of M2-2 motifs on cellular responses via an unbiased comparison. Tandem-Mass-Tagging (TMT) stable isotope labeling and high-resolution mass spectrometry were used for quantitative proteomic analysis. Quantitative proteomics and Venn analyses revealed there were 1248 common proteins detected in all infected samples of both technical sets. Hierachical clustering of the differentiated proteome displayed distinct proteomic signatures controlled by the motif(s). Bioinformatics and experimental analysis confirmed the differentiated proteomes, revealed novel cellular biological events, and implicated key pathways controlled by hMPV M2-2 motif(s), providing further insight into evaluating M2-2 mutants as potent vaccine candidates.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 8 Jun 2015
Tat Oyi-based candidate therapeutic vaccine: a successful phase 1 clinical trial in HIV-1 infected patients
Conference abstract
Vaccination with recombinant 4Ã?M2e.HSP70c fusion protein as a universal vaccine candidate enhances both humoral and cell-mediated immune responses and decreases viral shedding against experimental challenge of H9N2 in
Conference abstract · 6 Dec 2018
CHIM: Controlled human infection model for rapid screening of candidate vaccines
Review article · 2014
Recent Vaccine Development for Human Metapneumovirus
More from this journal
The newest in Journal of Vaccines & Clinical Trials.
Commentary · 28 Dec 2023
Cholera: A Historical Review, Epidemiology and Management
Commentary · 28 Dec 2023
Epidemiology and Global Impact of Dengue: Clinical Presentation and Disease Progression
Commentary · 28 Dec 2023
An Overview on Infectious Diseases: Its Global Impact and Challenges
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Clinical Trials
- SubjectPharmaceutical Sciences
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Xiaoyong Bao”
- BylineArticles whose byline prints “Yuping Ren”
- BylineArticles whose byline prints “Ke Zhang”
- BylineArticles whose byline prints “Yu Chen”
- BylineArticles whose byline prints “Xiaoling Deng”
- BylineArticles whose byline prints “Kangling Zhang”

